EGCG Reduces Obesity and White Adipose Tissue Gain Partly Through AMPK Activation in Mice
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
(-)-Epigallocatechin-3-gallate (EGCG), which is the most abundant catechin in green tea, has many potential health benefits, including decreased weight gain and/or adipose tissue weight. Suggested mechanisms for body weight reduction by EGCG include: (1) a decrease ining calorie intake; and (2) activationng of AMPK in liver, skeletal muscle, and white adipose tissue. However, only one study supports the AMPK hypothesis. To determine the role of AMPK in EGCG-induced reduction of body weight, we administrated 50 mg/kg and 100 mg/kg per day to mice, together with a high-fat diet (HFD), for 20 weeks. EGCG had a significant effect on the decrease obesity in body weight gain and decrease in epididymal adipose tissue weight, and also affected serum lipid characteristics, including, such as triglyceride (TAG), cholesterol (CHOL), and high- and low-density lipoprotein CHOL (HDL-C, LDL-C) concentrations. In addition, EGCG increased the excretion of free fatty acids from feces. By measuring the mRNA expression levels of genes involved in lipid metabolism, we found that EGCG inhibited the expression of genes involved in synthesis the synthesis of de novo fatty acids (acc1, fas, scd1, c/ebpβ, pparγ, and srebp1) and increased the expression of genes associated with lipolysis (hsl) and lipid oxidization in white adipose tissues, in both the HFD and the EGCG groups. However, EGCG could significantly increased the expression of genes involved in the synthesis of de novo fatty acids compared with the HFD group. Increased AMPK activity was found in both subcutaneous adipose tissues and in epididymal adipose tissues., In conclusion, EGCG can decrease obesity and epididymal white adipose tissue weight in mice, only partially via activation of AMPK.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
AMPK: a nutrient and energy sensor that maintains energy homeostasis
Hardie, D. G., Ross, F. A., & Hawley, S. A. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3311 · Cited by 4,602
AMP-activated protein kinase signaling in metabolic regulation
Long, Y. C. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29044 · Cited by 1,098 · cited 1×
“It has previously been reported that activation of AMPK inhibits activation of ACC, FASN, SREBP1, and PPARγ (Long and Zierath, 2006; Hardie et al., 2012, Hardie, 2015; Wang et al., 2018).”
BackgroundBose, M., Lambert, J. D., Ju, J., Reuhl, K. R., Shapses, S. A., & Yang, C. S. (2008) · The Journal of Nutrition · doi:10.1093/jn/138.9.1677 · Cited by 613 · cited 2×
“2 g/kg diet) for 16 weeks significantly reduced body weight gain, body fat percentage, and visceral fat weight in mice compared with those not receiving EGCG treatment (Bose et al., 2008).”
BackgroundObesity: assessment and management in primary care.
Lyznicki, J. M., Young, D., Riggs, J. A., & Davis, R. (2001) · PubMed · Cited by 488
AMPK: positive and negative regulation, and its role in whole-body energy homeostasis
Hardie, D. G. (2015) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2014.09.004 · Cited by 485 · cited 1×
“It has previously been reported that activation of AMPK inhibits activation of ACC, FASN, SREBP1, and PPARγ (Long and Zierath, 2006; Hardie et al., 2012, Hardie, 2015; Wang et al., 2018).”
BackgroundBERNARDIS, L. L., & PATTERSON, B. D. (1968) · Journal of Endocrinology · doi:10.1677/joe.0.0400527 · Cited by 480 · cited 1×
“331,000/body length (cm)], a widely used method to judge body weight and obesity in small-sized experimental animals (Lee, 1929; Bernardis and Patterson, 1968).”
MethodObesity and Cancer Risk: Recent Review and Evidence
Basen-Engquist, K., & Chang, M. (2011) · Current Oncology Reports · doi:10.1007/s11912-010-0139-7 · Cited by 439 · cited 1×
“There is a strong positive association between obesity and various chronic diseases, including type 2 diabetes, high blood pressure, cardiovascular disease, stroke, and even some cancers (Rossner, 2002; Basen-Engquist and Chang, 2011; Sartorius et al., 2016; Smith et al., 2017).”
BackgroundMechanisms of body weight reduction and metabolic syndrome alleviation by tea
Yang, C. S., Zhang, J., Zhang, L., Huang, J., & Wang, Y. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500428 · Cited by 384 · cited 3×
“has proposed that AMPK has a major role in mediating the effects of EGCG on fatty acid synthesis and fatty acid catabolism (Yang et al., 2016).”
BackgroundInfluentialSelf-citationAMPK-Mediated Regulation of Lipid Metabolism by Phosphorylation
Wang, Q., Liu, S., Zhai, A., Zhang, B., & Tian, G. (2018) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b17-00724 · Cited by 311 · cited 1×
“It has previously been reported that activation of AMPK inhibits activation of ACC, FASN, SREBP1, and PPARγ (Long and Zierath, 2006; Hardie et al., 2012, Hardie, 2015; Wang et al., 2018).”
BackgroundObesity: the disease of the twenty-first century
Rössner, S. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0802209 · Cited by 278 · cited 1×
“There is a strong positive association between obesity and various chronic diseases, including type 2 diabetes, high blood pressure, cardiovascular disease, stroke, and even some cancers (Rossner, 2002; Basen-Engquist and Chang, 2011; Sartorius et al., 2016; Smith et al., 2017).”
BackgroundLee, M.-S., Kim, C.-T., & Kim, Y. (2009) · Annals of Nutrition and Metabolism · doi:10.1159/000214834 · Cited by 215 · cited 2×
“Our results were partially consistent to previous studies of Lee et al. (2009) and Chen et al. (2011).”
Chen, Y.-K., Cheung, C., Reuhl, K. R., Liu, A. B., Lee, M.-J., Lu, Y.-P., & Yang, C. S. (2011) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf2029016 · Cited by 195 · cited 1×
“also found that EGCG treatment significantly reduced body weight gain in mice with high-fat/Western-style diet (HFW)-induced obesity, attenuated insulin resistance, and decreased blood glucose and liver TAG levels compared with the HFW-only group (Chen et al., 2011).”
BackgroundDietary composition and fat to sugar ratios in relation to obesity.
Bolton-Smith, C., & Woodward, M. (1994) · PubMed · Cited by 194
Beneficial Effects of Tea and the Green Tea Catechin Epigallocatechin-3-gallate on Obesity
Suzuki, T., Pervin, M., Goto, S., Isemura, M., & Nakamura, Y. (2016) · Molecules · doi:10.3390/molecules21101305 · Cited by 194 · cited 1×
“Several epidemiological studies revealed the beneficial effects of tea and EGCG on obesity in humans; however, the results were not always positive in human participant studies (Suzuki et al., 2016).”
ResultWeight control and prevention of metabolic syndrome by green tea
Sae-tan, S., Grove, K. A., & Lambert, J. D. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2010.12.013 · Cited by 178 · cited 1×
“EGCG has been reported to be responsible for many of the potential health benefits of green tea, including decreased weight gain and alleviated insulin resistance (Richard et al., 2009; Sae-tan et al., 2011).”
BackgroundOrtsäter, H., Grankvist, N., Wolfram, S., Kuehn, N., & Sjöholm, Å. (2012) · Nutrition & Metabolism · doi:10.1186/1743-7075-9-11 · Cited by 162 · cited 1×
“found that dietary supplementation of EGCG (1% of diet) significantly reduced body weight and also prevented the progression of glucose intolerance in db/db mice (Ortsater et al., 2012).”
BackgroundCatechin-induced activation of the LKB1/AMP-activated protein kinase pathway
Murase, T., Misawa, K., Haramizu, S., & Hase, T. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.03.021 · Cited by 154 · cited 1×
“However, only one study has reported activation of AMPK by EGCG in cultured cells and in liver tissues of mice, suggesting that the effects of catechins, including their anti-obesity and anti-cancer effects, are at least partially mediated by activation of AMPK (Murase et al., 2009).”
BackgroundFriedrich, M., Petzke, K. J., Raederstorff, D., Wolfram, S., & Klaus, S. (2011) · International Journal of Obesity · doi:10.1038/ijo.2011.136 · Cited by 135 · cited 1×
“EGCG has previously been shown to increase fecal lipid content, suggesting decreased digestion and absorption of lipids (Bose et al., 2008; Friedrich et al., 2012).”
BackgroundYeomans, M. R. (2017) · Proceedings of The Nutrition Society · doi:10.1017/s0029665117000805 · Cited by 134
Caesar, R., Manieri, M., Kelder, T., Boekschoten, M., Evelo, C., Müller, M., Kooistra, T., Cinti, S., Kleemann, R., & Drevon, C. A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011525 · Cited by 109 · cited 2×
“also found that the average cell area in epididymal adipose tissues was larger than that of adipocytes in subcutaneous and mesenteric adipose depots after 12 weeks HFD feeding in male transgenic ApoE3 Leiden mice (Caesar et al., 2010).”
BackgroundAre High-Fat, High-Sugar Foods and Diets Conducive to Obesity?
Gibson, S. A. (1996) · International Journal of Food Sciences and Nutrition · doi:10.3109/09637489609006954 · Cited by 89
Weight and plasma lipid control by decaffeinated green tea
Richard, D., Kefi, K., Barbe, U., Poli, A., Bausero, P., & Visioli, F. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.01.015 · Cited by 48 · cited 1×
“EGCG has been reported to be responsible for many of the potential health benefits of green tea, including decreased weight gain and alleviated insulin resistance (Richard et al., 2009; Sae-tan et al., 2011).”
BackgroundBaladía, E., Basulto, J., Manera, M., Martínez-Rodríguez, R., & Calbet, D. (2014) · PubMed · doi:10.3305/nh.2014.29.3.7118 · Cited by 44 · cited 1×
“For example, Baladia et al. performed a systematic review and meta-analysis, and found that green tea extracts had no statistically significant effect on the weight of overweight or obese adults; there was a small effect on the decrease in the percentage of fat mass (Baladia et al., 2014).”
BackgroundTranslating Mechanism-Based Strategies to Break the Obesity−Cancer Link: A Narrative Review
Smith, L. A., O’Flanagan, C. H., Bowers, L. W., Allott, E. H., & Hursting, S. D. (2017) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2017.08.112 · Cited by 37 · cited 1×
“There is a strong positive association between obesity and various chronic diseases, including type 2 diabetes, high blood pressure, cardiovascular disease, stroke, and even some cancers (Rossner, 2002; Basen-Engquist and Chang, 2011; Sartorius et al., 2016; Smith et al., 2017).”
BackgroundSartorius, B. K. D., Sartorius, K., Aldous, C. M., Madiba, T. E., Stefan, D. C., & Noakes, T. D. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-009301 · Cited by 32 · cited 1×
“There is a strong positive association between obesity and various chronic diseases, including type 2 diabetes, high blood pressure, cardiovascular disease, stroke, and even some cancers (Rossner, 2002; Basen-Engquist and Chang, 2011; Sartorius et al., 2016; Smith et al., 2017).”
BackgroundZambrano, E., & Nathanielsz, P. W. (2017) · The Journal of Physiology · doi:10.1113/jp274392 · Cited by 14 · cited 1×
“Overweight and obesity are usually caused by an energy imbalance between calorie intake and consumption, in particular, a high dietary intake of fats and sugars (BoltonSmith and Woodward, 1994; Gibson, 1996; Yeomans, 2017; Zambrano and Nathanielsz, 2017).”
Background
Cited by
Dietary polyphenols as antidiabetic agents: Advances and opportunities
Sun, C., Zhao, C., Guven, E. C., Paoli, P., Simal‐Gandara, J., Ramkumar, K. M., Wang, S., Buleu, F., Pah, A., Turi, V., et al. (2020) · Food Frontiers · doi:10.1002/fft2.15 · Cited by 305
Metadata
- Authors
- Li, F., Gao, C., Yan, P., Zhang, M., Wang, Y., Hu, Y., Wu, X., Wang, X., & Sheng, J.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2018-11-22
- Volume
- 9
- Pages
- 1366-1366
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W2900533089
- Cited by
- 178
- References
- 27
- FWCI
- 8.68
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.